Aminoglycoside Antibacterials

Name
Aminoglycoside Antibacterials
Accession Number
DBCAT000853  (DBCAT002397)
Description

A category of amino glycoside antibacterials. Must have an amino group attached to a glycoside and have antibacterial effects. Relation to Streptomyces spp. is considered important, but is not enough alone to allow for categorization here. Structurally, it must be an aminoglycoside. It must have antibacterial properties. It potentially came from a Streptomycin spp.

ATC Classification
Drugs
DrugDrug Description
AmikacinAn aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria.
TobramycinAn aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.
GentamicinAn aminoglycoside used to treat a wide variety of aerobic infections in the body.
NeomycinAn aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body.
StreptomycinAn aminoglycoside antibiotic indicated to treat multi-drug resistant mycobacterium tuberculosis and various non-tuberculosis infections.
FramycetinAn aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus.
NetilmicinAn aminoglycoside used to treat a wide variety of infections in the body.
KanamycinAn aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria.
ParomomycinAn aminoglycoside antibiotic used in the treatment of acute and chronic intestinal amebiasis, and as an adjunct for the management of hepatic coma.
RibostamycinA broad spectrum aminoglycoside antibiotic on the list of WHO critical antimicrobials for human medicine.
GeneticinGeneticin (also known as G418) is an aminoglycoside antibiotic similar in structure to gentamicin B1, produced by Micromonospora rhodorangea. Geneticin blocks polypeptide synthesis by inhibiting the elongation step in both...
ApramycinAn aminoglycoside antibiotic for veterinary use that is used to treat infections in animals.
Gentamicin C1aNot Available
NeamineNot Available
ArbekacinArbekacin is used for the short term treatment of multi-resistant bacterial infections, such as methicillin-resistant Staphylococcus aureus (MRSA).
PuromycinPuromycin is an antibiotic that prevents bacterial protein translation. It is utilized as a selective agent in laboratory cell cultures. Puromycin is toxic to both prokaryotic and eukaryotic cells, resulting...
DihydrostreptomycinDihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin...
Hygromycin BHygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis.
SisomicinSisomicin has been used in trials studying the treatment of Pyoderma.
PlazomicinAn aminoglycoside antibiotic used to treat complicated urinary tract infections.
DibekacinDibekacin is an aminoglycoside antibiotic marketed in Japan .
MicronomicinMicronomicin is an aminoglycoside antibiotic which is marketed in Japan, and sold under the brand names Sagamicin and Luxomicina.
IsepamicinNot Annotated
BekanamycinAn aminoglycoside antibiotic indicated in the treatment of eye infections.
CapreomycinAn aminoglycoside antibiotic used as an adjunct drug in tuberculosis.
ColistinA polymyxin antibiotic used to treat bacterial infections caused by susceptible Gram negative bacteria.
Nanoparticle EpirubicinNanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma). It is a novel epirubicin...
BerubicinNot Annotated
NC-6300NC-6300, also known as K-912, is a novel epirubicin drug-conjugated polymeric micelle.
Gentamicin C2Not Annotated
Drugs & Drug Targets
DrugTargetType
Amikacin30S ribosomal protein S12target
Tobramycin16S ribosomal RNAtarget
TobramycinBacterial outer membranetarget
TobramycinCytoplasmic membranetarget
Tobramycin23S ribosomal RNAtarget
Gentamicin30S ribosomal protein S12target
Gentamicin16S ribosomal RNAtarget
GentamicinNH(3)-dependent NAD(+) synthetasetarget
GentamicinDihydrofolate reductasetarget
Gentamicin23S ribosomal RNAtarget
GentamicinBacterial outer membranetarget
GentamicinCytoplasmic membranetarget
GentamicinLow-density lipoprotein receptor-related protein 2transporter
GentamicinSolute carrier family 22 member 2transporter
GentamicinCanalicular multispecific organic anion transporter 1transporter
Neomycin30S ribosomal protein S12target
Neomycin16S ribosomal RNAtarget
NeomycinExtracellular calcium-sensing receptortarget
Streptomycin30S ribosomal protein S12target
Streptomycin16S ribosomal RNAtarget
StreptomycinProtein-arginine deiminase type-4target
Streptomycin23S ribosomal RNAtarget
StreptomycinBacterial outer membranetarget
StreptomycinCytoplasmic membranetarget
Framycetin30S ribosomal protein S12target
Framycetin16S ribosomal RNAtarget
FramycetinC-X-C chemokine receptor type 4target
Netilmicin30S ribosomal protein S12target
Netilmicin16S ribosomal RNAtarget
Kanamycin30S ribosomal protein S12target
Kanamycin16S ribosomal RNAtarget
KanamycinAminoglycoside 2'-N-acetyltransferaseenzyme
KanamycinKanamycin nucleotidyltransferaseenzyme
KanamycinAminoglycoside 3'-phosphotransferaseenzyme
Paromomycin16S ribosomal RNAtarget
Paromomycin30S ribosomal protein S10target
Paromomycin40S ribosomal protein SAtarget
Paromomycin60S ribosomal protein L10-liketarget
RibostamycinProtein disulfide-isomerasetarget
Ribostamycin30S ribosomal protein S12target
RibostamycinAminoglycoside N(6')-acetyltransferase type 1target
RibostamycinAminoglycoside 2'-N-acetyltransferasetarget
RibostamycinAminoglycoside 2'-N-acetyltransferaseenzyme
GeneticinOrnithine decarboxylasetarget
Apramycin16S ribosomal RNAtarget
Gentamicin C1a30S ribosomal protein S12target
Gentamicin C1a16S ribosomal RNAtarget
Arbekacin30S ribosomal protein S12target
Puromycin60S ribosomal protein L10-liketarget
Puromycin60S ribosomal protein L13atarget
Puromycin60S ribosomal protein L23target
Puromycin60S ribosomal protein L15target
Puromycin60S ribosomal protein L19target
Puromycin60S ribosomal protein L23atarget
PuromycinProbable ribosome biogenesis protein RLP24target
Puromycin60S ribosomal protein L26-like 1target
Puromycin60S ribosomal protein L8target
Puromycin60S ribosomal protein L37target
Puromycin60S ribosomal protein L3target
Puromycin60S ribosomal protein L11target
PuromycinLeucyl/phenylalanyl-tRNA--protein transferasetarget
PlazomicinMultidrug and toxin extrusion protein 1transporter
PlazomicinMultidrug and toxin extrusion protein 2transporter
Plazomicin30S ribosomal protein S14target
Plazomicin30S ribosomal protein S11target
Capreomycin16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyAtarget
ColistinBacterial outer membranetarget